A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance Mechanisms to Osimertinib in Adjuvant Treatment of Completely Resected pIB-IIIA Non-small Cell Lung Carcinoma With Common EGFR Mutations (L858R and Del19)
NA
IFCT-2202 ROSIE study aims to incorporate a broad-panel centralized NGS tes...
Evaluation of the Cell Detachment Ratio on pH-responsive Chitosan as a Prognostic Factor in Lung Cancer
N/A
Biomaterial-based cell culture models have been gaining increasing attentio...
Status
Unknown
Location
National Taiwan University Hospital
Start Date
2020-01-05
Trial ID
NCT04218188
Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia
N/A
The goal of this observational study is to characterize the diagnostic and ...
Status
Recruiting
Location
Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico